메뉴 건너뛰기




Volumn 24, Issue 4, 2014, Pages 685-687

Successful treatment of eosinophilic granulomatosis with polyangiitis (EGPA; Formerly ChurgStrauss syndrome) with rituximab in a case refractory to glucocorticoids, cyclophosphamide, and IVIG

Author keywords

Eosinophilic granulomatosis with polyangiitis; IVIG; Rituximab

Indexed keywords

C REACTIVE PROTEIN; CYCLOPHOSPHAMIDE; EOSINOPHIL CATIONIC PROTEIN; IMMUNOGLOBULIN; IMMUNOGLOBULIN G; METHYLPREDNISOLONE; RITUXIMAB; GLUCOCORTICOID; IMMUNOLOGIC FACTOR; MONOCLONAL ANTIBODY;

EID: 84901934296     PISSN: 14397595     EISSN: 14397609     Source Type: Journal    
DOI: 10.3109/14397595.2013.874734     Document Type: Article
Times cited : (22)

References (17)
  • 1
    • 34248526053 scopus 로고    scopus 로고
    • Churg-Strauss syndrome with poor-prognosis factors: A prospective multicenter trial comparing glucocorticoids and six or twelve cyclophosphamide pulses in forty-eight patients
    • Cohen P, Pagnoux C, Mahr A, Arene JP, Mouthon L, Le Guern V, et al. Churg-Strauss syndrome with poor-prognosis factors: a prospective multicenter trial comparing glucocorticoids and six or twelve cyclophosphamide pulses in forty-eight patients. Arthritis Rheum. 2007;57:686-93.
    • (2007) Arthritis Rheum. , vol.57 , pp. 686-693
    • Cohen, P.1    Pagnoux, C.2    Mahr, A.3    Arene, J.P.4    Mouthon, L.5    Le Guern, V.6
  • 2
    • 61449238213 scopus 로고    scopus 로고
    • EULAR recommendations for the management of primary small and medium vessel vasculitis
    • Mukhtyar C, Guillevin L, Cid MC, Dasgupta B, de Groot K, Gross W, et al. EULAR recommendations for the management of primary small and medium vessel vasculitis. Ann Rheum Dis. 2009;68:310-17.
    • (2009) Ann Rheum Dis. , vol.68 , pp. 310-317
    • Mukhtyar, C.1    Guillevin, L.2    Cid, M.C.3    Dasgupta, B.4    De Groot, K.5    Gross, W.6
  • 3
    • 34250869590 scopus 로고    scopus 로고
    • Treatment for Churg-Strauss syndrome: Induction of remission and efficacy of intravenous immunoglobulin therapy
    • Taniguchi M, Tsurikisawa N, Higashi N, Saito H, Mita H, Mori A, et al. Treatment for Churg-Strauss syndrome: induction of remission and efficacy of intravenous immunoglobulin therapy. Allergol Int. 2007;56:97-103.
    • (2007) Allergol Int. , vol.56 , pp. 97-103
    • Taniguchi, M.1    Tsurikisawa, N.2    Higashi, N.3    Saito, H.4    Mita, H.5    Mori, A.6
  • 6
    • 33746499655 scopus 로고    scopus 로고
    • Successful use of rituximab in a patient with recalcitrant Churg-Strauss syndrome
    • Kaushik VV, Reddy HV, Bucknall RC. Successful use of rituximab in a patient with recalcitrant Churg-Strauss syndrome. Ann Rheum Dis. 2006;65:1116-7.
    • (2006) Ann Rheum Dis. , vol.65 , pp. 1116-1117
    • Kaushik, V.V.1    Reddy, H.V.2    Bucknall, R.C.3
  • 8
    • 45749109391 scopus 로고    scopus 로고
    • Rituximab is Effective in the treatment of refractory Churg-Strauss syndrome and is associated with diminished T-cell interleukin-5 production
    • Pepper RJ, Fabre MA, Pavesio C, Gaskin G, Jones RB, Jayne D, et al. Rituximab is Effective in the treatment of refractory Churg-Strauss syndrome and is associated with diminished T-cell interleukin-5 production. Rheumatology (Oxford). 2008;47:1104-5.
    • (2008) Rheumatology (Oxford). , vol.47 , pp. 1104-1105
    • Pepper, R.J.1    Fabre, M.A.2    Pavesio, C.3    Gaskin, G.4    Jones, R.B.5    Jayne, D.6
  • 9
    • 77953688485 scopus 로고    scopus 로고
    • Successful use of rituximab in a patient with Churg-Strauss syndrome and refractory central nervous system involvement
    • Saech J, Owczarczyk K, Rosgen S, Petereit H, Hallek M, Rubbert-Roth A. Successful use of rituximab in a patient with Churg-Strauss syndrome and refractory central nervous system involvement. Ann Rheum Dis. 2010;69:1254-5.
    • (2010) Ann Rheum Dis. , vol.69 , pp. 1254-1255
    • Saech, J.1    Owczarczyk, K.2    Rosgen, S.3    Petereit, H.4    Hallek, M.5    Rubbert-Roth, A.6
  • 10
    • 78751583954 scopus 로고    scopus 로고
    • Churg-Strauss syndrome successfully treated with rituximab
    • Donvik KK, Omdal R. Churg-Strauss syndrome successfully treated with rituximab. Rheumatol Int. 2011;31:89-91.
    • (2011) Rheumatol Int. , vol.31 , pp. 89-91
    • Donvik, K.K.1    Omdal, R.2
  • 12
    • 0036884344 scopus 로고    scopus 로고
    • Immunomodulatory action of intravenous immunoglobulin
    • Sewell WA, Jolles S. Immunomodulatory action of intravenous immunoglobulin. Immunology. 2002;107:387-93.
    • (2002) Immunology. , vol.107 , pp. 387-393
    • Sewell, W.A.1    Jolles, S.2
  • 13
    • 84860751767 scopus 로고    scopus 로고
    • High-dose intravenous immunoglobulin treatment increases regulatory T cells in patients with eosinophilic granulomatosis with polyangiitis
    • Tsurikisawa N, Saito H, Oshikata C, Tsuburai T, Akiyama K. High-dose intravenous immunoglobulin treatment increases regulatory T cells in patients with eosinophilic granulomatosis with polyangiitis. J Rheumatol. 2012;39:1019-25.
    • (2012) J Rheumatol. , vol.39 , pp. 1019-1025
    • Tsurikisawa, N.1    Saito, H.2    Oshikata, C.3    Tsuburai, T.4    Akiyama, K.5
  • 15
    • 84863763157 scopus 로고    scopus 로고
    • Extended follow-up after stopping mepolizumab in relapsing/refractory Churg-Strauss syndrome
    • Herrmann K, Gross WL, Moosig F. Extended follow-up after stopping mepolizumab in relapsing/refractory Churg-Strauss syndrome. Clin Exp Rheumatol. 2012;30:S62-5.
    • (2012) Clin Exp Rheumatol. , vol.30
    • Herrmann, K.1    Gross, W.L.2    Moosig, F.3
  • 16
    • 34648840838 scopus 로고    scopus 로고
    • Serum eosinophil cationic protein: A marker of disease activity in Churg-Strauss syndrome
    • Guilpain P, Auclair JF, Tamby MC, Servettaz A, Mahr A, Weill B, et al. Serum eosinophil cationic protein: a marker of disease activity in Churg-Strauss syndrome. Ann N Y Acad Sci. 2007;1107: 392-9.
    • (2007) Ann N y Acad Sci. , vol.1107 , pp. 392-399
    • Guilpain, P.1    Auclair, J.F.2    Tamby, M.C.3    Servettaz, A.4    Mahr, A.5    Weill, B.6
  • 17
    • 0033659034 scopus 로고    scopus 로고
    • Usefulness of serum eosinophil cationic protein (ECP) in predicting relapse of Churg and Strauss vasculitis
    • Hurst S, Chizzolini C, Dayer JM, Olivieri J, Roux-Lombard P. Usefulness of serum eosinophil cationic protein (ECP) in predicting relapse of Churg and Strauss vasculitis. Clin Exp Rheumatol. 2000;18:784-5.
    • (2000) Clin Exp Rheumatol. , vol.18 , pp. 784-785
    • Hurst, S.1    Chizzolini, C.2    Dayer, J.M.3    Olivieri, J.4    Roux-Lombard, P.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.